{"protocolSection":{"identificationModule":{"nctId":"NCT00958126","orgStudyIdInfo":{"id":"CSLCT-CAL-09-61"},"organization":{"fullName":"Seqirus","class":"INDUSTRY"},"briefTitle":"A Clinical Trial of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Adults in the USA","officialTitle":"A Phase II, Multicenter, Randomized, Observer-Blind, Placebo-Controlled Study to Evaluate the Immunogenicity, Safety and Tolerability of CSL's 2009 H1N1 Influenza Vaccine (CSL425) in Healthy Adults Aged 18 Years and Older"},"statusModule":{"statusVerifiedDate":"2017-10","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2009-08"},"primaryCompletionDateStruct":{"date":"2009-11","type":"ACTUAL"},"completionDateStruct":{"date":"2010-04","type":"ACTUAL"},"studyFirstSubmitDate":"2009-08-12","studyFirstSubmitQcDate":"2009-08-12","studyFirstPostDateStruct":{"date":"2009-08-13","type":"ESTIMATED"},"resultsFirstSubmitDate":"2012-07-05","resultsFirstSubmitQcDate":"2012-08-31","resultsFirstPostDateStruct":{"date":"2012-10-03","type":"ESTIMATED"},"lastUpdateSubmitDate":"2017-10-18","lastUpdatePostDateStruct":{"date":"2017-11-21","type":"ACTUAL"}},"sponsorCollaboratorsModule":{"responsibleParty":{"type":"SPONSOR"},"leadSponsor":{"name":"Seqirus","class":"INDUSTRY"}},"oversightModule":{"oversightHasDmc":true},"descriptionModule":{"briefSummary":"The purpose of this study is to determine whether CSL425 is a safe and effective vaccine for eliciting an immune response to H1N1 influenza in healthy adults"},"conditionsModule":{"conditions":["Influenza"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE2"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"PREVENTION","maskingInfo":{"masking":"QUADRUPLE","whoMasked":["PARTICIPANT","CARE_PROVIDER","INVESTIGATOR","OUTCOMES_ASSESSOR"]}},"enrollmentInfo":{"count":1313,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"CSL425 (7.5 mcg)","type":"EXPERIMENTAL","description":"7.5 mcg of hemagglutinin antigen per dose. 0.25 mL intramuscular injection into the deltoid region of the arm on Day 0 and Day 21","interventionNames":["Biological: CSL425"]},{"label":"CSL425 (15 mcg)","type":"EXPERIMENTAL","description":"15 mcg of hemagglutinin antigen per dose. 0.25 mL intramuscular injection into the deltoid region of the arm on Day 0 and Day 21.","interventionNames":["Biological: CSL425"]},{"label":"CSL425 (30 mcg)","type":"EXPERIMENTAL","description":"30 mcg of hemagglutinin antigen per dose. 0.5 mL intramuscular injection into the deltoid region of the arm on Day 0 and Day 21","interventionNames":["Biological: CSL425"]},{"label":"Placebo","type":"PLACEBO_COMPARATOR","description":"Vaccine diluent. 0.5 mL intramuscular injection into the deltoid region of the arm on Day 0 and Day 21.","interventionNames":["Biological: Placebo"]}],"interventions":[{"type":"BIOLOGICAL","name":"CSL425","description":"CSL's 2009 H1N1 Influenza Vaccine, thimerosal-free.","armGroupLabels":["CSL425 (7.5 mcg)"]},{"type":"BIOLOGICAL","name":"CSL425","description":"CSL's 2009 H1N1 Influenza Vaccine, thimerosal 0.01% (weight/volume).","armGroupLabels":["CSL425 (15 mcg)","CSL425 (30 mcg)"]},{"type":"BIOLOGICAL","name":"Placebo","description":"Vaccine diluent, thimerosal 0.01% (weight/volume).","armGroupLabels":["Placebo"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Seroconversion Rate 21 Days After the First Vaccination","description":"Seroconversion rate: the proportion of participants achieving seroconversion in hemagglutination inhibition (HI) antibody titer. Seroconversion is defined as participants with a baseline titer of less than 1:10 achieving a post-vaccination HI antibody titer of 1:40 or more; or participants with a baseline HI titer of 1:10 or more achieving a four-fold or greater increase in post-vaccination HI titer.","timeFrame":"21 days after the first vaccination"},{"measure":"Seroconversion Rate 21 Days After the Second Vaccination","description":"Seroconversion rate: the percentage of participants achieving seroconversion in HI antibody titer. Seroconversion is defined as participants with a pre-vaccination titer of less than 1:10 achieving a post-vaccination HI antibody titer of 1:40 or more; or participants with a pre-vaccination HI titer of 1:10 or more achieving a four-fold or greater increase in post-vaccination HI titer.","timeFrame":"21 days after the second vaccination"},{"measure":"Percentage of Participants Achieving an Hemagglutination Inhibition (HI) Antibody Titer of 1:40 or More 21 Days After the First Vaccination","timeFrame":"21 days after the first vaccination"},{"measure":"Percentage of Participants Achieving an HI Antibody Titer of 1:40 or More 21 Days After the Second Vaccination","timeFrame":"21 days after the second vaccination"}],"secondaryOutcomes":[{"measure":"Frequency and Intensity of Solicited Adverse Events After the First Vaccination","description":"Grade 3 solicited adverse event (AE) definitions: Prevented normal daily activities; Size \\> 100 mm for injection site redness or induration/swelling; Temperature 102.2°F (39.0°C) or more for fevers.","timeFrame":"During the 7 days after the first vaccination"},{"measure":"Duration of Solicited Local Adverse Events After the First Vaccination","timeFrame":"During the 7 days after the first vaccination, and day 7 - day 21 for ongoing AEs"},{"measure":"Incidence of Serious Adverse Events (SAEs), Adverse Events of Special Interest (AESI) and New Onset of Chronic Illness (NOCI)","description":"A NOCI was defined as the diagnosis of a new medical condition that was chronic in nature, including those potentially controllable by medication (eg, diabetes, asthma).","timeFrame":"Up to 180 days after the last vaccination"},{"measure":"Frequency and Intensity of Unsolicited Adverse Events (UAE) After the First or Second Vaccination","description":"Unsolicited adverse event (UAE) grading:\n\nGrade 1 (mild): Symptoms were easily tolerated and did not interfere with daily activities.\n\nGrade 2 (moderate): Enough discomfort to cause some interference with daily activities.\n\nGrade 3 (severe): Symptoms that prevented normal, everyday activities.","timeFrame":"Day 0 to Day 20 after each vaccination; up to Day 180 after the last vaccination for SAEs, AESI and NOCI"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Male or female aged 18 and older, inclusive, at the time of providing informed consent.\n* Females of child bearing potential (i.e., ovulating, pre-menopausal, not surgically sterile) must be abstinent or be willing to use a medically accepted contraceptive regimen for the duration of the study. Females of child bearing potential must return a negative urine pregnancy test result at enrolment and prior to each study vaccination.\n\nExclusion Criteria:\n\n* Known hypersensitivity to a previous dose of influenza virus vaccine or allergy to eggs, chicken protein, thimerosal, neomycin, polymyxin, or any components of the Study Vaccine.","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Director, Vaccines Clinical Development","affiliation":"Seqirus","role":"STUDY_DIRECTOR"}],"locations":[{"facility":"Study Site","city":"Huntsville","state":"Alabama","zip":"35802","country":"United States","geoPoint":{"lat":34.7304,"lon":-86.58594}},{"facility":"Study Site","city":"San Diego","state":"California","zip":"92108","country":"United States","geoPoint":{"lat":32.71571,"lon":-117.16472}},{"facility":"Study Site","city":"Melbourne","state":"Florida","zip":"32935","country":"United States","geoPoint":{"lat":28.08363,"lon":-80.60811}},{"facility":"Study Site","city":"Peoria","state":"Illinois","zip":"61602","country":"United States","geoPoint":{"lat":40.69365,"lon":-89.58899}},{"facility":"Study Site","city":"South Bend","state":"Indiana","zip":"46601","country":"United States","geoPoint":{"lat":41.68338,"lon":-86.25001}},{"facility":"Study Site","city":"Metairie","state":"Louisiana","zip":"70006","country":"United States","geoPoint":{"lat":29.98409,"lon":-90.15285}},{"facility":"Study Site","city":"Baltimore","state":"Maryland","zip":"21205","country":"United States","geoPoint":{"lat":39.29038,"lon":-76.61219}},{"facility":"Study Site","city":"Rockville","state":"Maryland","zip":"20850","country":"United States","geoPoint":{"lat":39.084,"lon":-77.15276}},{"facility":"Study Site","city":"Austin","state":"Texas","zip":"78705","country":"United States","geoPoint":{"lat":30.26715,"lon":-97.74306}},{"facility":"Study Site","city":"Fort Worth","state":"Texas","zip":"76135","country":"United States","geoPoint":{"lat":32.72541,"lon":-97.32085}},{"facility":"Study Site","city":"Salt Lake City","state":"Utah","zip":"84124","country":"United States","geoPoint":{"lat":40.76078,"lon":-111.89105}}]},"referencesModule":{"references":[{"pmid":"20874515","type":"RESULT","citation":"Talaat KR, Greenberg ME, Lai MH, Hartel GF, Wichems CH, Rockman S, Jeanfreau RJ, Ghosh MR, Kabongo ML, Gittleson C, Karron RA. A single dose of unadjuvanted novel 2009 H1N1 vaccine is immunogenic and well tolerated in young and elderly adults. J Infect Dis. 2010 Nov 1;202(9):1327-37. doi: 10.1086/656601."}]}},"resultsSection":{"participantFlowModule":{"groups":[{"id":"FG000","title":"Placebo, Adults","description":"Vaccine diluent; Adults aged 18 to 64 years"},{"id":"FG001","title":"CSL425 (7.5 mcg), Adults","description":"7.5 mcg of hemagglutinin antigen per dose; Adults aged 18 to 64 years"},{"id":"FG002","title":"CSL425 (15 Mcg), Adults","description":"15 mcg of hemagglutinin antigen per dose; Adults aged 18 to 64 years"},{"id":"FG003","title":"CSL425 (30 Mcg), Adults","description":"30 mcg of hemagglutinin antigen per dose; Adults aged 18 to 64 years"},{"id":"FG004","title":"Placebo, Older Adults","description":"Vaccine diluent; Older adults aged 65 years or older"},{"id":"FG005","title":"CSL425 (7.5 Mcg), Older Adults","description":"7.5 mcg of hemagglutinin antigen per dose; Older adults aged 65 years or older"},{"id":"FG006","title":"CSL425 (15 Mcg), Older Adults","description":"15 mcg of hemagglutinin antigen per dose; Older adults aged 65 years or older"},{"id":"FG007","title":"CSL425 (30 Mcg), Older Adults","description":"30 mcg of hemagglutinin antigen per dose; Older adults aged 65 years or older"}],"periods":[{"title":"Overall Study","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","numSubjects":"49"},{"groupId":"FG001","numSubjects":"205"},{"groupId":"FG002","numSubjects":"201"},{"groupId":"FG003","numSubjects":"203"},{"groupId":"FG004","numSubjects":"50"},{"groupId":"FG005","numSubjects":"203"},{"groupId":"FG006","numSubjects":"200"},{"groupId":"FG007","numSubjects":"202"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"48"},{"groupId":"FG001","numSubjects":"196"},{"groupId":"FG002","numSubjects":"191"},{"groupId":"FG003","numSubjects":"192"},{"groupId":"FG004","numSubjects":"50"},{"groupId":"FG005","numSubjects":"202"},{"groupId":"FG006","numSubjects":"199"},{"groupId":"FG007","numSubjects":"202"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"9"},{"groupId":"FG002","numSubjects":"10"},{"groupId":"FG003","numSubjects":"11"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"1"},{"groupId":"FG006","numSubjects":"1"},{"groupId":"FG007","numSubjects":"0"}]}],"dropWithdraws":[{"type":"Serious Adverse Event","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"2"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"1"},{"groupId":"FG007","numSubjects":"0"}]},{"type":"Withdrawal by Subject","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"2"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"0"}]},{"type":"Moved away from study area","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"1"},{"groupId":"FG003","numSubjects":"1"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"0"}]},{"type":"Lost to Follow-up","reasons":[{"groupId":"FG000","numSubjects":"1"},{"groupId":"FG001","numSubjects":"5"},{"groupId":"FG002","numSubjects":"9"},{"groupId":"FG003","numSubjects":"8"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"0"}]},{"type":"Sponsor/Investigator decision","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"1"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"0"}]},{"type":"Other Reason","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"1"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"1"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"0"}]}]}]},"baselineCharacteristicsModule":{"groups":[{"id":"BG000","title":"Placebo, Adults","description":"Vaccine diluent; Adults aged 18 to 64 years"},{"id":"BG001","title":"CSL425 (7.5 mcg), Adults","description":"7.5 mcg of hemagglutinin antigen per dose; Adults aged 18 to 64 years"},{"id":"BG002","title":"CSL425 (15 Mcg), Adults","description":"15 mcg of hemagglutinin antigen per dose; Adults aged 18 to 64 years"},{"id":"BG003","title":"CSL425 (30 Mcg), Adults","description":"30 mcg of hemagglutinin antigen per dose; Adults aged 18 to 64 years"},{"id":"BG004","title":"Placebo, Older Adults","description":"Vaccine diluent; Older adults aged 65 years or older"},{"id":"BG005","title":"CSL425 (7.5 Mcg), Older Adults","description":"7.5 mcg of hemagglutinin antigen per dose; Older adults aged 65 years or older"},{"id":"BG006","title":"CSL425 (15 Mcg), Older Adults","description":"15 mcg of hemagglutinin antigen per dose; Older adults aged 65 years or older"},{"id":"BG007","title":"CSL425 (30 Mcg), Older Adults","description":"30 mcg of hemagglutinin antigen per dose; Older adults aged 65 years or older"},{"id":"BG008","title":"Total","description":"Total of all reporting groups"}],"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"49"},{"groupId":"BG001","value":"205"},{"groupId":"BG002","value":"201"},{"groupId":"BG003","value":"203"},{"groupId":"BG004","value":"50"},{"groupId":"BG005","value":"203"},{"groupId":"BG006","value":"200"},{"groupId":"BG007","value":"202"},{"groupId":"BG008","value":"1313"}]}],"measures":[{"title":"Age, Customized","paramType":"NUMBER","unitOfMeasure":"participants","classes":[{"title":">= 18 years to 64 years","categories":[{"measurements":[{"groupId":"BG000","value":"49"},{"groupId":"BG001","value":"205"},{"groupId":"BG002","value":"201"},{"groupId":"BG003","value":"203"},{"groupId":"BG004","value":"0"},{"groupId":"BG005","value":"0"},{"groupId":"BG006","value":"0"},{"groupId":"BG007","value":"0"},{"groupId":"BG008","value":"658"}]}]},{"title":">=65 years","categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"},{"groupId":"BG004","value":"50"},{"groupId":"BG005","value":"203"},{"groupId":"BG006","value":"200"},{"groupId":"BG007","value":"202"},{"groupId":"BG008","value":"655"}]}]}]},{"title":"Sex: Female, Male","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Female","measurements":[{"groupId":"BG000","value":"31"},{"groupId":"BG001","value":"123"},{"groupId":"BG002","value":"113"},{"groupId":"BG003","value":"113"},{"groupId":"BG004","value":"29"},{"groupId":"BG005","value":"120"},{"groupId":"BG006","value":"108"},{"groupId":"BG007","value":"112"},{"groupId":"BG008","value":"749"}]},{"title":"Male","measurements":[{"groupId":"BG000","value":"18"},{"groupId":"BG001","value":"82"},{"groupId":"BG002","value":"88"},{"groupId":"BG003","value":"90"},{"groupId":"BG004","value":"21"},{"groupId":"BG005","value":"83"},{"groupId":"BG006","value":"92"},{"groupId":"BG007","value":"90"},{"groupId":"BG008","value":"564"}]}]}]}]},"outcomeMeasuresModule":{"outcomeMeasures":[{"type":"PRIMARY","title":"Seroconversion Rate 21 Days After the First Vaccination","description":"Seroconversion rate: the proportion of participants achieving seroconversion in hemagglutination inhibition (HI) antibody titer. Seroconversion is defined as participants with a baseline titer of less than 1:10 achieving a post-vaccination HI antibody titer of 1:40 or more; or participants with a baseline HI titer of 1:10 or more achieving a four-fold or greater increase in post-vaccination HI titer.","populationDescription":"The Evaluable Population (for the first vaccination) comprised all randomized participants who received the first study vaccination; provided both pre- and post-vaccination blood samples; were not excluded from analyses (eg, for the use of a prohibited medication or a laboratory-confirmed 2009 H1N1 infection between Visit 1 and Visit 3).","reportingStatus":"POSTED","paramType":"NUMBER","dispersionType":"95% Confidence Interval","unitOfMeasure":"percentage of participants","timeFrame":"21 days after the first vaccination","groups":[{"id":"OG000","title":"Placebo, Adults","description":"Vaccine diluent; Adults aged 18 to 64 years"},{"id":"OG001","title":"CSL425 (7.5 mcg), Adults","description":"7.5 mcg of hemagglutinin antigen per dose; Adults aged 18 to 64 years"},{"id":"OG002","title":"CSL425 (15 Mcg), Adults","description":"15 mcg of hemagglutinin antigen per dose; Adults aged 18 to 64 years"},{"id":"OG003","title":"CSL425 (30 Mcg), Adults","description":"30 mcg of hemagglutinin antigen per dose; Adults aged 18 to 64 years"},{"id":"OG004","title":"Placebo, Older Adults","description":"Vaccine diluent; Older adults aged 65 years or older"},{"id":"OG005","title":"CSL425 (7.5 Mcg), Older Adults","description":"7.5 mcg of hemagglutinin antigen per dose; Older adults aged 65 years or older"},{"id":"OG006","title":"CSL425 (15 Mcg), Older Adults","description":"15 mcg of hemagglutinin antigen per dose; Older adults aged 65 years or older"},{"id":"OG007","title":"CSL425 (30 Mcg), Older Adults","description":"30 mcg of hemagglutinin antigen per dose; Older adults aged 65 years or older"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"48"},{"groupId":"OG001","value":"200"},{"groupId":"OG002","value":"195"},{"groupId":"OG003","value":"199"},{"groupId":"OG004","value":"48"},{"groupId":"OG005","value":"201"},{"groupId":"OG006","value":"197"},{"groupId":"OG007","value":"200"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0","lowerLimit":"0.0","upperLimit":"7.4"},{"groupId":"OG001","value":"82","lowerLimit":"76.0","upperLimit":"87.1"},{"groupId":"OG002","value":"88.2","lowerLimit":"82.8","upperLimit":"92.4"},{"groupId":"OG003","value":"94.5","lowerLimit":"90.3","upperLimit":"97.2"},{"groupId":"OG004","value":"2.1","lowerLimit":"0.1","upperLimit":"11.1"},{"groupId":"OG005","value":"51.2","lowerLimit":"44.1","upperLimit":"58.3"},{"groupId":"OG006","value":"58.9","lowerLimit":"51.7","upperLimit":"65.8"},{"groupId":"OG007","value":"73.0","lowerLimit":"66.3","upperLimit":"79.0"}]}]}]},{"type":"SECONDARY","title":"Frequency and Intensity of Solicited Adverse Events After the First Vaccination","description":"Grade 3 solicited adverse event (AE) definitions: Prevented normal daily activities; Size \\> 100 mm for injection site redness or induration/swelling; Temperature 102.2°F (39.0°C) or more for fevers.","populationDescription":"The Safety Population (first vaccination) comprised all randomized participants who received the first vaccination and provided follow-up safety data.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"percentage of participants","timeFrame":"During the 7 days after the first vaccination","groups":[{"id":"OG000","title":"Placebo, Adults","description":"Vaccine diluent; Adults aged 18 to 64 years"},{"id":"OG001","title":"CSL425 (7.5 mcg), Adults","description":"7.5 mcg of hemagglutinin antigen per dose; Adults aged 18 to 64 years"},{"id":"OG002","title":"CSL425 (15 Mcg), Adults","description":"15 mcg of hemagglutinin antigen per dose; Adults aged 18 to 64 years"},{"id":"OG003","title":"CSL425 (30 Mcg), Adults","description":"30 mcg of hemagglutinin antigen per dose; Adults aged 18 to 64 years"},{"id":"OG004","title":"Placebo, Older Adults","description":"Vaccine diluent; Older adults aged 65 years or older"},{"id":"OG005","title":"CSL425 (7.5 Mcg), Older Adults","description":"7.5 mcg of hemagglutinin antigen per dose; Older adults aged 65 years or older"},{"id":"OG006","title":"CSL425 (15 Mcg), Older Adults","description":"15 mcg of hemagglutinin antigen per dose; Older adults aged 65 years or older"},{"id":"OG007","title":"CSL425 (30 Mcg), Older Adults","description":"30 mcg of hemagglutinin antigen per dose; Older adults aged 65 years or older"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"49"},{"groupId":"OG001","value":"204"},{"groupId":"OG002","value":"201"},{"groupId":"OG003","value":"203"},{"groupId":"OG004","value":"50"},{"groupId":"OG005","value":"203"},{"groupId":"OG006","value":"200"},{"groupId":"OG007","value":"202"}]}],"classes":[{"title":"Any local solicited adverse event","categories":[{"measurements":[{"groupId":"OG000","value":"22.4","lowerLimit":"11.8","upperLimit":"36.6"},{"groupId":"OG001","value":"28.9","lowerLimit":"22.8","upperLimit":"35.7"},{"groupId":"OG002","value":"35.8","lowerLimit":"29.2","upperLimit":"42.9"},{"groupId":"OG003","value":"52.7","lowerLimit":"45.6","upperLimit":"59.7"},{"groupId":"OG004","value":"4.0"},{"groupId":"OG005","value":"13.3"},{"groupId":"OG006","value":"23.5"},{"groupId":"OG007","value":"21.8"}]}]},{"title":"Any pain at injection site","categories":[{"measurements":[{"groupId":"OG000","value":"14.3","lowerLimit":"5.9","upperLimit":"27.2"},{"groupId":"OG001","value":"14.7","lowerLimit":"10.1","upperLimit":"20.3"},{"groupId":"OG002","value":"17.4","lowerLimit":"12.4","upperLimit":"23.4"},{"groupId":"OG003","value":"31.0","lowerLimit":"24.7","upperLimit":"37.9"},{"groupId":"OG004","value":"2.0"},{"groupId":"OG005","value":"2.0"},{"groupId":"OG006","value":"4.0"},{"groupId":"OG007","value":"6.9"}]}]},{"title":"Grade 3 pain at injection site","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0.5"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"0"}]}]},{"title":"Any redness at injection site","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1.0"},{"groupId":"OG002","value":"0.5"},{"groupId":"OG003","value":"1.0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0.5"},{"groupId":"OG006","value":"1.0"},{"groupId":"OG007","value":"0"}]}]},{"title":"Grade 3 redness at injection site","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"0"}]}]},{"title":"Any swelling/induration at injection site","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"3.9"},{"groupId":"OG002","value":"2.5"},{"groupId":"OG003","value":"3.9"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"2.0"},{"groupId":"OG006","value":"3.0"},{"groupId":"OG007","value":"2.5"}]}]},{"title":"Grade 3 swelling/induration at injection site","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"0"}]}]},{"title":"Any tenderness at injection site","categories":[{"measurements":[{"groupId":"OG000","value":"18.4"},{"groupId":"OG001","value":"23.5"},{"groupId":"OG002","value":"32.8"},{"groupId":"OG003","value":"46.8"},{"groupId":"OG004","value":"4.0"},{"groupId":"OG005","value":"10.3"},{"groupId":"OG006","value":"20.0"},{"groupId":"OG007","value":"18.3"}]}]},{"title":"Grade 3 tenderness at injection site","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"0"}]}]},{"title":"Any bruising at injection site","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"4.4"},{"groupId":"OG002","value":"4.0"},{"groupId":"OG003","value":"1.0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"1.5"},{"groupId":"OG006","value":"3.0"},{"groupId":"OG007","value":"1.5"}]}]},{"title":"Grade 3 bruising at injection site","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"0"}]}]},{"title":"Any solicited systemic adverse event","categories":[{"measurements":[{"groupId":"OG000","value":"28.6"},{"groupId":"OG001","value":"35.3"},{"groupId":"OG002","value":"34.8"},{"groupId":"OG003","value":"40.9"},{"groupId":"OG004","value":"18.0"},{"groupId":"OG005","value":"16.7"},{"groupId":"OG006","value":"24.0"},{"groupId":"OG007","value":"22.8"}]}]},{"title":"Any headache","categories":[{"measurements":[{"groupId":"OG000","value":"16.3"},{"groupId":"OG001","value":"19.6"},{"groupId":"OG002","value":"21.4"},{"groupId":"OG003","value":"27.1"},{"groupId":"OG004","value":"8.0"},{"groupId":"OG005","value":"9.4"},{"groupId":"OG006","value":"10.5"},{"groupId":"OG007","value":"10.4"}]}]},{"title":"Grade 3 headache","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1.0"},{"groupId":"OG002","value":"1.0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0.5"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"0.5"}]}]},{"title":"Any malaise","categories":[{"measurements":[{"groupId":"OG000","value":"8.2"},{"groupId":"OG001","value":"10.8"},{"groupId":"OG002","value":"16.4"},{"groupId":"OG003","value":"17.2"},{"groupId":"OG004","value":"10.0"},{"groupId":"OG005","value":"5.4"},{"groupId":"OG006","value":"9.5"},{"groupId":"OG007","value":"11.9"}]}]},{"title":"Grade 3 malaise","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1.0"},{"groupId":"OG002","value":"1.0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"0"}]}]},{"title":"Any myalgia","categories":[{"measurements":[{"groupId":"OG000","value":"4.1"},{"groupId":"OG001","value":"14.7"},{"groupId":"OG002","value":"15.9"},{"groupId":"OG003","value":"17.7"},{"groupId":"OG004","value":"8.0"},{"groupId":"OG005","value":"8.9"},{"groupId":"OG006","value":"13.0"},{"groupId":"OG007","value":"13.4"}]}]},{"title":"Grade 3 myalgia","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0.5"},{"groupId":"OG002","value":"0.5"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"0"}]}]},{"title":"Any nausea","categories":[{"measurements":[{"groupId":"OG000","value":"4.1"},{"groupId":"OG001","value":"6.4"},{"groupId":"OG002","value":"8.0"},{"groupId":"OG003","value":"7.9"},{"groupId":"OG004","value":"2.0"},{"groupId":"OG005","value":"1.0"},{"groupId":"OG006","value":"2.5"},{"groupId":"OG007","value":"3.5"}]}]},{"title":"Grade 3 nausea","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0.5"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0.5"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"0"}]}]},{"title":"Any chills","categories":[{"measurements":[{"groupId":"OG000","value":"2.0"},{"groupId":"OG001","value":"3.9"},{"groupId":"OG002","value":"5.0"},{"groupId":"OG003","value":"5.4"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0.5"},{"groupId":"OG006","value":"1.0"},{"groupId":"OG007","value":"3.0"}]}]},{"title":"Grade 3 chills","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0.5"},{"groupId":"OG002","value":"0.5"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"0"}]}]},{"title":"Any vomiting","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2.9"},{"groupId":"OG002","value":"1.0"},{"groupId":"OG003","value":"1.0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0.5"},{"groupId":"OG007","value":"0.5"}]}]},{"title":"Grade 3 vomiting","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0.5"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"0"}]}]},{"title":"Any fever","categories":[{"measurements":[{"groupId":"OG000","value":"2.0"},{"groupId":"OG001","value":"3.4"},{"groupId":"OG002","value":"3.0"},{"groupId":"OG003","value":"3.4"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0.5"},{"groupId":"OG007","value":"0.5"}]}]},{"title":"Grade 3 fever","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0.5"},{"groupId":"OG002","value":"1.0"},{"groupId":"OG003","value":"0.5"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"0"}]}]}]},{"type":"SECONDARY","title":"Duration of Solicited Local Adverse Events After the First Vaccination","populationDescription":"The Safety Population (first vaccination) comprised all randomized participants who received the first vaccination and provided follow-up safety data.","reportingStatus":"POSTED","paramType":"MEAN","dispersionType":"Standard Deviation","unitOfMeasure":"days","timeFrame":"During the 7 days after the first vaccination, and day 7 - day 21 for ongoing AEs","groups":[{"id":"OG000","title":"Placebo, Adults","description":"Vaccine diluent; Adults aged 18 to 64 years"},{"id":"OG001","title":"CSL425 (7.5 mcg), Adults","description":"7.5 mcg of hemagglutinin antigen per dose; Adults aged 18 to 64 years"},{"id":"OG002","title":"CSL425 (15 Mcg), Adults","description":"15 mcg of hemagglutinin antigen per dose; Adults aged 18 to 64 years"},{"id":"OG003","title":"CSL425 (30 Mcg), Adults","description":"30 mcg of hemagglutinin antigen per dose; Adults aged 18 to 64 years"},{"id":"OG004","title":"Placebo, Older Adults","description":"Vaccine diluent; Older adults aged 65 years or older"},{"id":"OG005","title":"CSL425 (7.5 Mcg), Older Adults","description":"7.5 mcg of hemagglutinin antigen per dose; Older adults aged 65 years or older"},{"id":"OG006","title":"CSL425 (15 Mcg), Older Adults","description":"15 mcg of hemagglutinin antigen per dose; Older adults aged 65 years or older"},{"id":"OG007","title":"CSL425 (30 Mcg), Older Adults","description":"30 mcg of hemagglutinin antigen per dose; Older adults aged 65 years or older"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"49"},{"groupId":"OG001","value":"204"},{"groupId":"OG002","value":"201"},{"groupId":"OG003","value":"203"},{"groupId":"OG004","value":"50"},{"groupId":"OG005","value":"203"},{"groupId":"OG006","value":"200"},{"groupId":"OG007","value":"202"}]}],"classes":[{"title":"Pain at injection site","categories":[{"measurements":[{"groupId":"OG000","value":"1.14","spread":"0.378"},{"groupId":"OG001","value":"1.87","spread":"2.705"},{"groupId":"OG002","value":"1.71","spread":"0.926"},{"groupId":"OG003","value":"1.91","spread":"1.237"},{"groupId":"OG004","value":"1.00","spread":"NA","comment":"n = 1"},{"groupId":"OG005","value":"1.75","spread":"0.957"},{"groupId":"OG006","value":"1.75","spread":"0.886"},{"groupId":"OG007","value":"1.27","spread":"0.594"}]}]},{"title":"Redness at injection site","categories":[{"measurements":[{"groupId":"OG000","value":"NA","spread":"NA","comment":"n = 0"},{"groupId":"OG001","value":"1.00","spread":"0.000"},{"groupId":"OG002","value":"1.00","spread":"NA","comment":"n = 1"},{"groupId":"OG003","value":"2.50","spread":"0.707"},{"groupId":"OG004","value":"NA","spread":"NA","comment":"n = 0"},{"groupId":"OG005","value":"1.00","spread":"NA","comment":"n = 1"},{"groupId":"OG006","value":"1.00","spread":"0.000"},{"groupId":"OG007","value":"NA","spread":"NA","comment":"n = 0"}]}]},{"title":"Swelling/induration at injection site","categories":[{"measurements":[{"groupId":"OG000","value":"NA","spread":"NA","comment":"n = 0"},{"groupId":"OG001","value":"1.56","spread":"0.726"},{"groupId":"OG002","value":"1.2","spread":"0.447"},{"groupId":"OG003","value":"3.38","spread":"2.615"},{"groupId":"OG004","value":"NA","spread":"NA","comment":"n = 0"},{"groupId":"OG005","value":"6.00","spread":"10.00"},{"groupId":"OG006","value":"1.5","spread":"0.837"},{"groupId":"OG007","value":"3.2","spread":"4.382"}]}]},{"title":"Tenderness at injection site","categories":[{"measurements":[{"groupId":"OG000","value":"2.1","spread":"1.912"},{"groupId":"OG001","value":"2.04","spread":"2.813"},{"groupId":"OG002","value":"1.85","spread":"0.966"},{"groupId":"OG003","value":"1.90","spread":"1.082"},{"groupId":"OG004","value":"1.5","spread":"0.707"},{"groupId":"OG005","value":"1.27","spread":"0.550"},{"groupId":"OG006","value":"1.71","spread":"0.955"},{"groupId":"OG007","value":"1.65","spread":"1.075"}]}]},{"title":"Bruising at injection site","categories":[{"measurements":[{"groupId":"OG000","value":"NA","spread":"NA","comment":"n = 0"},{"groupId":"OG001","value":"3.00","spread":"2.539"},{"groupId":"OG002","value":"2.25","spread":"1.669"},{"groupId":"OG003","value":"2.00","spread":"0.000"},{"groupId":"OG004","value":"NA","spread":"NA","comment":"n = 0"},{"groupId":"OG005","value":"8.00","spread":"11.269"},{"groupId":"OG006","value":"4.33","spread":"2.503"},{"groupId":"OG007","value":"1.20","spread":"0.447"}]}]}]},{"type":"PRIMARY","title":"Seroconversion Rate 21 Days After the Second Vaccination","description":"Seroconversion rate: the percentage of participants achieving seroconversion in HI antibody titer. Seroconversion is defined as participants with a pre-vaccination titer of less than 1:10 achieving a post-vaccination HI antibody titer of 1:40 or more; or participants with a pre-vaccination HI titer of 1:10 or more achieving a four-fold or greater increase in post-vaccination HI titer.","populationDescription":"The Evaluable Population (for the second vaccination) comprised all randomized participants who received the second study vaccine; provided both pre- and post-vaccination blood samples; were not excluded from analyses (eg, for the use of a prohibited medication or a laboratory-confirmed 2009 H1N1 infection between Visit 1 and Visit 3).","reportingStatus":"POSTED","paramType":"NUMBER","dispersionType":"95% Confidence Interval","unitOfMeasure":"percentage of participants","timeFrame":"21 days after the second vaccination","groups":[{"id":"OG000","title":"Placebo, Adults","description":"Vaccine diluent; Adults aged 18 to 64 years"},{"id":"OG001","title":"CSL425 (7.5 mcg), Adults","description":"7.5 mcg of hemagglutinin antigen per dose; Adults aged 18 to 64 years"},{"id":"OG002","title":"CSL425 (15 Mcg), Adults","description":"15 mcg of hemagglutinin antigen per dose; Adults aged 18 to 64 years"},{"id":"OG003","title":"CSL425 (30 Mcg), Adults","description":"30 mcg of hemagglutinin antigen per dose; Adults aged 18 to 64 years"},{"id":"OG004","title":"Placebo, Older Adults","description":"Vaccine diluent; Older adults aged 65 years or older"},{"id":"OG005","title":"CSL425 (7.5 Mcg), Older Adults","description":"7.5 mcg of hemagglutinin antigen per dose; Older adults aged 65 years or older"},{"id":"OG006","title":"CSL425 (15 Mcg), Older Adults","description":"15 mcg of hemagglutinin antigen per dose; Older adults aged 65 years or older"},{"id":"OG007","title":"CSL425 (30 Mcg), Older Adults","description":"30 mcg of hemagglutinin antigen per dose; Older adults aged 65 years or older"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"48"},{"groupId":"OG001","value":"196"},{"groupId":"OG002","value":"191"},{"groupId":"OG003","value":"193"},{"groupId":"OG004","value":"48"},{"groupId":"OG005","value":"200"},{"groupId":"OG006","value":"196"},{"groupId":"OG007","value":"198"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.3","lowerLimit":"1.3","upperLimit":"17.2"},{"groupId":"OG001","value":"83.2","lowerLimit":"77.2","upperLimit":"88.1"},{"groupId":"OG002","value":"91.1","lowerLimit":"86.1","upperLimit":"94.7"},{"groupId":"OG003","value":"95.9","lowerLimit":"92.0","upperLimit":"98.2"},{"groupId":"OG004","value":"8.3","lowerLimit":"2.3","upperLimit":"20.0"},{"groupId":"OG005","value":"59.5","lowerLimit":"52.3","upperLimit":"66.4"},{"groupId":"OG006","value":"67.3","lowerLimit":"60.3","upperLimit":"73.9"},{"groupId":"OG007","value":"75.3","lowerLimit":"68.6","upperLimit":"81.1"}]}]}]},{"type":"PRIMARY","title":"Percentage of Participants Achieving an Hemagglutination Inhibition (HI) Antibody Titer of 1:40 or More 21 Days After the First Vaccination","populationDescription":"The Evaluable Population (for the first vaccination) comprised all randomized participants who received the first study vaccination; provided both pre- and post-vaccination blood samples; were not excluded from analyses (eg, for the use of a prohibited medication or a laboratory-confirmed 2009 H1N1 infection between Visit 1 and Visit 3).","reportingStatus":"POSTED","paramType":"NUMBER","dispersionType":"95% Confidence Interval","unitOfMeasure":"percentage of participants","timeFrame":"21 days after the first vaccination","groups":[{"id":"OG000","title":"Placebo, Adults","description":"Vaccine diluent; Adults aged 18 to 64 years"},{"id":"OG001","title":"CSL425 (7.5 mcg), Adults","description":"7.5 mcg of hemagglutinin antigen per dose; Adults aged 18 to 64 years"},{"id":"OG002","title":"CSL425 (15 Mcg), Adults","description":"15 mcg of hemagglutinin antigen per dose; Adults aged 18 to 64 years"},{"id":"OG003","title":"CSL425 (30 Mcg), Adults","description":"30 mcg of hemagglutinin antigen per dose; Adults aged 18 to 64 years"},{"id":"OG004","title":"Placebo, Older Adults","description":"Vaccine diluent; Older adults aged 65 years or older"},{"id":"OG005","title":"CSL425 (7.5 Mcg), Older Adults","description":"7.5 mcg of hemagglutinin antigen per dose; Older adults aged 65 years or older"},{"id":"OG006","title":"CSL425 (15 Mcg), Older Adults","description":"15 mcg of hemagglutinin antigen per dose; Older adults aged 65 years or older"},{"id":"OG007","title":"CSL425 (30 Mcg), Older Adults","description":"30 mcg of hemagglutinin antigen per dose; Older adults aged 65 years or older"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"48"},{"groupId":"OG001","value":"200"},{"groupId":"OG002","value":"195"},{"groupId":"OG003","value":"199"},{"groupId":"OG004","value":"48"},{"groupId":"OG005","value":"201"},{"groupId":"OG006","value":"197"},{"groupId":"OG007","value":"200"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"22.9","lowerLimit":"12.0","upperLimit":"37.3"},{"groupId":"OG001","value":"97.0","lowerLimit":"93.6","upperLimit":"98.9"},{"groupId":"OG002","value":"96.4","lowerLimit":"92.7","upperLimit":"98.5"},{"groupId":"OG003","value":"99.5","lowerLimit":"97.2","upperLimit":"100.0"},{"groupId":"OG004","value":"39.6","lowerLimit":"25.8","upperLimit":"54.7"},{"groupId":"OG005","value":"92.0","lowerLimit":"87.4","upperLimit":"95.4"},{"groupId":"OG006","value":"90.9","lowerLimit":"85.9","upperLimit":"94.5"},{"groupId":"OG007","value":"94.0","lowerLimit":"89.8","upperLimit":"96.9"}]}]}]},{"type":"PRIMARY","title":"Percentage of Participants Achieving an HI Antibody Titer of 1:40 or More 21 Days After the Second Vaccination","populationDescription":"The Evaluable Population (for the second vaccination) comprised all randomized participants who received the second study vaccination; provided both pre- and post-vaccination blood samples; were not excluded from analyses (eg, for the use of a prohibited medication or a laboratory-confirmed 2009 H1N1 infection between Visit 1 and Visit 3).","reportingStatus":"POSTED","paramType":"NUMBER","dispersionType":"95% Confidence Interval","unitOfMeasure":"percentage of participants","timeFrame":"21 days after the second vaccination","groups":[{"id":"OG000","title":"Placebo, Adults","description":"Vaccine diluent; Adults aged 18 to 64 years"},{"id":"OG001","title":"CSL425 (7.5 mcg), Adults","description":"7.5 mcg of hemagglutinin antigen per dose; Adults aged 18 to 64 years"},{"id":"OG002","title":"CSL425 (15 Mcg), Adults","description":"15 mcg of hemagglutinin antigen per dose; Adults aged 18 to 64 years"},{"id":"OG003","title":"CSL425 (30 Mcg), Adults","description":"30 mcg of hemagglutinin antigen per dose; Adults aged 18 to 64 years"},{"id":"OG004","title":"Placebo, Older Adults","description":"Vaccine diluent; Older adults aged 65 years or older"},{"id":"OG005","title":"CSL425 (7.5 Mcg), Older Adults","description":"7.5 mcg of hemagglutinin antigen per dose; Older adults aged 65 years or older"},{"id":"OG006","title":"CSL425 (15 Mcg), Older Adults","description":"15 mcg of hemagglutinin antigen per dose; Older adults aged 65 years or older"},{"id":"OG007","title":"CSL425 (30 Mcg), Older Adults","description":"30 mcg of hemagglutinin antigen per dose; Older adults aged 65 years or older"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"48"},{"groupId":"OG001","value":"196"},{"groupId":"OG002","value":"191"},{"groupId":"OG003","value":"193"},{"groupId":"OG004","value":"48"},{"groupId":"OG005","value":"200"},{"groupId":"OG006","value":"196"},{"groupId":"OG007","value":"198"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"29.2","lowerLimit":"17.0","upperLimit":"44.1"},{"groupId":"OG001","value":"98.5","lowerLimit":"95.6","upperLimit":"99.7"},{"groupId":"OG002","value":"99.5","lowerLimit":"97.1","upperLimit":"100.0"},{"groupId":"OG003","value":"99.5","lowerLimit":"97.1","upperLimit":"100.0"},{"groupId":"OG004","value":"35.4","lowerLimit":"22.2","upperLimit":"50.5"},{"groupId":"OG005","value":"96.0","lowerLimit":"92.3","upperLimit":"98.3"},{"groupId":"OG006","value":"93.4","lowerLimit":"88.9","upperLimit":"96.4"},{"groupId":"OG007","value":"94.9","lowerLimit":"90.9","upperLimit":"97.6"}]}]}]},{"type":"SECONDARY","title":"Incidence of Serious Adverse Events (SAEs), Adverse Events of Special Interest (AESI) and New Onset of Chronic Illness (NOCI)","description":"A NOCI was defined as the diagnosis of a new medical condition that was chronic in nature, including those potentially controllable by medication (eg, diabetes, asthma).","populationDescription":"The Safety Population comprised all randomized participants who received at least one dose of study vaccine and provided follow-up safety data.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"percentage of participants","timeFrame":"Up to 180 days after the last vaccination","groups":[{"id":"OG000","title":"Placebo, Adults","description":"Vaccine diluent; Adults aged 18 to 64 years"},{"id":"OG001","title":"CSL425 (7.5 mcg), Adults","description":"7.5 mcg of hemagglutinin antigen per dose; Adults aged 18 to 64 years"},{"id":"OG002","title":"CSL425 (15 Mcg), Adults","description":"15 mcg of hemagglutinin antigen per dose; Adults aged 18 to 64 years"},{"id":"OG003","title":"CSL425 (30 Mcg), Adults","description":"30 mcg of hemagglutinin antigen per dose; Adults aged 18 to 64 years"},{"id":"OG004","title":"Placebo, Older Adults","description":"Vaccine diluent; Older adults aged 65 years or older"},{"id":"OG005","title":"CSL425 (7.5 Mcg), Older Adults","description":"7.5 mcg of hemagglutinin antigen per dose; Older adults aged 65 years or older"},{"id":"OG006","title":"CSL425 (15 Mcg), Older Adults","description":"15 mcg of hemagglutinin antigen per dose; Older adults aged 65 years or older"},{"id":"OG007","title":"CSL425 (30 Mcg), Older Adults","description":"30 mcg of hemagglutinin antigen per dose; Older adults aged 65 years or older"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"49"},{"groupId":"OG001","value":"204"},{"groupId":"OG002","value":"201"},{"groupId":"OG003","value":"203"},{"groupId":"OG004","value":"50"},{"groupId":"OG005","value":"203"},{"groupId":"OG006","value":"200"},{"groupId":"OG007","value":"202"}]}],"classes":[{"title":"Percentage of participants with at least one SAE","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"2.9"},{"groupId":"OG002","value":"2.0"},{"groupId":"OG003","value":"1.5"},{"groupId":"OG004","value":"6.0"},{"groupId":"OG005","value":"4.4"},{"groupId":"OG006","value":"3.0"},{"groupId":"OG007","value":"4.5"}]}]},{"title":"Percentage of participants with related SAE","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"0"}]}]},{"title":"Percentage of participants with at least one AESI","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"0"}]}]},{"title":"Percentage of participants with related AESI","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"0"}]}]},{"title":"Percentage of participants with at least one NOCI","categories":[{"measurements":[{"groupId":"OG000","value":"4.1"},{"groupId":"OG001","value":"0.5"},{"groupId":"OG002","value":"0.5"},{"groupId":"OG003","value":"0.5"},{"groupId":"OG004","value":"2.0"},{"groupId":"OG005","value":"1.0"},{"groupId":"OG006","value":"2.5"},{"groupId":"OG007","value":"2.0"}]}]},{"title":"Percentage of participants with related NOCI","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"0"}]}]}]},{"type":"SECONDARY","title":"Frequency and Intensity of Unsolicited Adverse Events (UAE) After the First or Second Vaccination","description":"Unsolicited adverse event (UAE) grading:\n\nGrade 1 (mild): Symptoms were easily tolerated and did not interfere with daily activities.\n\nGrade 2 (moderate): Enough discomfort to cause some interference with daily activities.\n\nGrade 3 (severe): Symptoms that prevented normal, everyday activities.","populationDescription":"The Safety Population comprised all randomized participants who received at least one dose of study vaccine and provided follow-up safety data.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"percentage of participants","timeFrame":"Day 0 to Day 20 after each vaccination; up to Day 180 after the last vaccination for SAEs, AESI and NOCI","groups":[{"id":"OG000","title":"Placebo, Age Cohorts Combined","description":"Vaccine diluent"},{"id":"OG001","title":"CSL425 (7.5 mcg), Age Cohorts Combined","description":"7.5 mcg of hemagglutinin antigen per dose"},{"id":"OG002","title":"CSL425 (15 Mcg), Age Cohorts Combined","description":"15 mcg of hemagglutinin antigen per dose"},{"id":"OG003","title":"CSL425 (30 Mcg), Age Cohorts Combined","description":"30 mcg of hemagglutinin antigen per dose"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"99"},{"groupId":"OG001","value":"407"},{"groupId":"OG002","value":"401"},{"groupId":"OG003","value":"405"}]}],"classes":[{"title":"Percentage of participants with at least one UAE","categories":[{"measurements":[{"groupId":"OG000","value":"27.3"},{"groupId":"OG001","value":"27.5"},{"groupId":"OG002","value":"30.2"},{"groupId":"OG003","value":"27.9"}]}]},{"title":"Percentage of participants reporting Grade 1 UAE","categories":[{"measurements":[{"groupId":"OG000","value":"7.1"},{"groupId":"OG001","value":"12.8"},{"groupId":"OG002","value":"10.0"},{"groupId":"OG003","value":"12.8"}]}]},{"title":"Percentage of participants reporting Grade 2 UAE","categories":[{"measurements":[{"groupId":"OG000","value":"15.2"},{"groupId":"OG001","value":"8.8"},{"groupId":"OG002","value":"14.0"},{"groupId":"OG003","value":"10.4"}]}]},{"title":"Percentage of participants reporting Grade 3 UAE","categories":[{"measurements":[{"groupId":"OG000","value":"5.1"},{"groupId":"OG001","value":"5.9"},{"groupId":"OG002","value":"6.2"},{"groupId":"OG003","value":"4.7"}]}]}]}]},"adverseEventsModule":{"frequencyThreshold":"2","timeFrame":"For SAEs: up to 180 days after the last vaccination. For unsolicited adverse events: 21 days after the first study vaccination, up to 180 days after the the last vaccination (for AESI and NOCI).","description":"Serious Adverse Events were collected from Day 0 to 180 days after the last vaccination.\n\nThe other adverse events presented are unsolicited adverse events from Day 0 to Day 20 days after the first study vaccination, AESI and NOCI from Day 0 to 180 days after the last vaccination.","eventGroups":[{"id":"EG000","title":"Placebo, Adults","description":"Vaccine diluent; Adults aged 18 to 64 years","seriousNumAffected":0,"seriousNumAtRisk":49,"otherNumAffected":12,"otherNumAtRisk":49},{"id":"EG001","title":"CSL425 (7.5 mcg), Adults","description":"7.5 mcg of hemagglutinin antigen per dose; Adults aged 18 to 64 years","seriousNumAffected":6,"seriousNumAtRisk":204,"otherNumAffected":27,"otherNumAtRisk":204},{"id":"EG002","title":"CSL425 (15 Mcg), Adults","description":"15 mcg of hemagglutinin antigen per dose; Adults aged 18 to 64 years","seriousNumAffected":4,"seriousNumAtRisk":201,"otherNumAffected":25,"otherNumAtRisk":201},{"id":"EG003","title":"CSL425 (30 Mcg), Adults","description":"30 mcg of hemagglutinin antigen per dose; Adults aged 18 to 64 years","seriousNumAffected":3,"seriousNumAtRisk":203,"otherNumAffected":27,"otherNumAtRisk":203},{"id":"EG004","title":"Placebo, Older Adults","description":"Vaccine diluent; Older adults aged 65 years or older","seriousNumAffected":3,"seriousNumAtRisk":50,"otherNumAffected":5,"otherNumAtRisk":50},{"id":"EG005","title":"CSL425 (7.5 Mcg), Older Adults","description":"7.5 mcg of hemagglutinin antigen per dose; Older adults aged 65 years or older","seriousNumAffected":9,"seriousNumAtRisk":203,"otherNumAffected":20,"otherNumAtRisk":203},{"id":"EG006","title":"CSL425 (15 Mcg), Older Adults","description":"15 mcg of hemagglutinin antigen per dose; Older adults aged 65 years or older","seriousNumAffected":6,"seriousNumAtRisk":200,"otherNumAffected":23,"otherNumAtRisk":200},{"id":"EG007","title":"CSL425 (30 Mcg), Older Adults","description":"30 mcg of hemagglutinin antigen per dose; Older adults aged 65 years or older","seriousNumAffected":9,"seriousNumAtRisk":202,"otherNumAffected":18,"otherNumAtRisk":202}],"seriousEvents":[{"term":"Pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":204},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":50},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":203},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":200},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":202}]},{"term":"Appendicitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":200},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":202}]},{"term":"Cellulitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":200},{"groupId":"EG007","numEvents":2,"numAffected":2,"numAtRisk":202}]},{"term":"Subcutaneous abscess","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":200},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":202}]},{"term":"Viral infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":200},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":202}]},{"term":"Anaemia","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":200},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":202}]},{"term":"Myocardial infarction","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":200},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":202}]},{"term":"Chronic obstructive pulmonary disease","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":200},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":202}]},{"term":"Sleep apnoea syndrome","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":200},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":202}]},{"term":"Umbilical hernia, obstructive","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":200},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":202}]},{"term":"Urinary retention","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":200},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":202}]},{"term":"Atrial septal defect","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":200},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":202}]},{"term":"Fibrous dysplasia of bone","organSystem":"Congenital, familial and genetic disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":200},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":202}]},{"term":"Accidental overdose","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":200},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":202}]},{"term":"Acute sinusitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":203},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":200},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":202}]},{"term":"Arthritis bacterial","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":200},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":202}]},{"term":"Viral myocarditis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":200},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":202}]},{"term":"Lip and/or oral cavity cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":200},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":202}]},{"term":"Lung metastatic cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":200},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":202}]},{"term":"Lung neoplasm malignant","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":203},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":200},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":202}]},{"term":"Prostate cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":200},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":202}]},{"term":"Renal cell carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":200},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":202}]},{"term":"Tonsil cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":200},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":202}]},{"term":"Disseminated intravascular coagulation","organSystem":"Blood and lymphatic system disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":200},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":202}]},{"term":"Presyncope","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":203},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":200},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":202}]},{"term":"Atrial fibrillation","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG006","numEvents":2,"numAffected":2,"numAtRisk":200},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":202}]},{"term":"Acute myocardial infarction","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":200},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":202}]},{"term":"Cardiac failure","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":203},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":200},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":202}]},{"term":"Pericarditis","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":50},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":200},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":202}]},{"term":"Ventricular fibrillation","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":200},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":202}]},{"term":"Asthma","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":203},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":200},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":202}]},{"term":"Pulmonary embolism","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":203},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":200},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":202}]},{"term":"Respiratory distress","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":200},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":202}]},{"term":"Athralgia","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":203},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":200},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":202}]},{"term":"Arthritis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":203},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":200},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":202}]},{"term":"Osteoarthritis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":50},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":200},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":202}]},{"term":"Torticollis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":200},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":202}]},{"term":"Urinary bladder haemorrhage","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":200},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":202}]},{"term":"Prostatic obstruction","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":200},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":202}]},{"term":"Acetabulum fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":203},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":200},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":202}]},{"term":"Arterial injury","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":200},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":202}]},{"term":"Humerus fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":200},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":202}]}],"otherEvents":[{"term":"Nasopharyngitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":49},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":204},{"groupId":"EG002","numEvents":5,"numAffected":4,"numAtRisk":201},{"groupId":"EG003","numEvents":3,"numAffected":3,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":203},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":200},{"groupId":"EG007","numEvents":2,"numAffected":2,"numAtRisk":202}]},{"term":"Oral herpes","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":49},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":204},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":201},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":200},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":202}]},{"term":"Rhinitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":49},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":2,"numAffected":2,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":200},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":202}]},{"term":"Pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":200},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":202}]},{"term":"Urinary tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":49},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":203},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":200},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":202}]},{"term":"Anxiety","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":200},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":202}]},{"term":"Insomnia","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":200},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":202}]},{"term":"Depression","organSystem":"Psychiatric disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":200},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":202}]},{"term":"Headache","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":4,"numAffected":2,"numAtRisk":49},{"groupId":"EG001","numEvents":8,"numAffected":8,"numAtRisk":204},{"groupId":"EG002","numEvents":7,"numAffected":5,"numAtRisk":201},{"groupId":"EG003","numEvents":4,"numAffected":4,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":8,"numAffected":7,"numAtRisk":203},{"groupId":"EG006","numEvents":3,"numAffected":3,"numAtRisk":200},{"groupId":"EG007","numEvents":2,"numAffected":2,"numAtRisk":202}]},{"term":"Hypertension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":2,"numAffected":2,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":203},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":200},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":202}]},{"term":"Oropharyngeal pain","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":49},{"groupId":"EG001","numEvents":6,"numAffected":6,"numAtRisk":204},{"groupId":"EG002","numEvents":8,"numAffected":8,"numAtRisk":201},{"groupId":"EG003","numEvents":8,"numAffected":8,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":203},{"groupId":"EG006","numEvents":2,"numAffected":2,"numAtRisk":200},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":202}]},{"term":"Cough","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":49},{"groupId":"EG001","numEvents":5,"numAffected":5,"numAtRisk":204},{"groupId":"EG002","numEvents":7,"numAffected":7,"numAtRisk":201},{"groupId":"EG003","numEvents":9,"numAffected":9,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":4,"numAffected":3,"numAtRisk":203},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":200},{"groupId":"EG007","numEvents":4,"numAffected":4,"numAtRisk":202}]},{"term":"Nasal congestion","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":204},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":201},{"groupId":"EG003","numEvents":7,"numAffected":7,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":200},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":202}]},{"term":"Asthma","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":200},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":202}]},{"term":"Diarrhoea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":49},{"groupId":"EG001","numEvents":4,"numAffected":4,"numAtRisk":204},{"groupId":"EG002","numEvents":2,"numAffected":1,"numAtRisk":201},{"groupId":"EG003","numEvents":2,"numAffected":2,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":203},{"groupId":"EG006","numEvents":5,"numAffected":5,"numAtRisk":200},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":202}]},{"term":"Nausea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":49},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":204},{"groupId":"EG002","numEvents":2,"numAffected":1,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":50},{"groupId":"EG005","numEvents":2,"numAffected":2,"numAtRisk":203},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":200},{"groupId":"EG007","numEvents":2,"numAffected":2,"numAtRisk":202}]},{"term":"Myalgia","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":49},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":204},{"groupId":"EG002","numEvents":2,"numAffected":1,"numAtRisk":201},{"groupId":"EG003","numEvents":3,"numAffected":3,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":203},{"groupId":"EG006","numEvents":3,"numAffected":2,"numAtRisk":200},{"groupId":"EG007","numEvents":4,"numAffected":4,"numAtRisk":202}]},{"term":"Back pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":2,"numAffected":2,"numAtRisk":201},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":203},{"groupId":"EG006","numEvents":3,"numAffected":3,"numAtRisk":200},{"groupId":"EG007","numEvents":4,"numAffected":2,"numAtRisk":202}]},{"term":"Pain in extremity","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":49},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":2,"numAffected":1,"numAtRisk":203},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":200},{"groupId":"EG007","numEvents":1,"numAffected":1,"numAtRisk":202}]},{"term":"Muscle spasms","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":203},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":200},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":202}]},{"term":"Pyrexia","organSystem":"General disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":204},{"groupId":"EG002","numEvents":5,"numAffected":5,"numAtRisk":201},{"groupId":"EG003","numEvents":3,"numAffected":2,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG006","numEvents":2,"numAffected":2,"numAtRisk":200},{"groupId":"EG007","numEvents":2,"numAffected":2,"numAtRisk":202}]},{"term":"Malaise","organSystem":"General disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":1,"numAffected":1,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":203},{"groupId":"EG004","numEvents":0,"numAffected":0,"numAtRisk":50},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":203},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":200},{"groupId":"EG007","numEvents":4,"numAffected":4,"numAtRisk":202}]},{"term":"Hyperlipidaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":203},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":50},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":200},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":202}]},{"term":"Ear pain","organSystem":"Ear and labyrinth disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":1,"numAffected":1,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":50},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":203},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":200},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":202}]},{"term":"Rhinorrhoea","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":2,"numAffected":2,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":3,"numAffected":3,"numAtRisk":203},{"groupId":"EG004","numEvents":2,"numAffected":1,"numAtRisk":50},{"groupId":"EG005","numEvents":3,"numAffected":2,"numAtRisk":203},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":200},{"groupId":"EG007","numEvents":2,"numAffected":2,"numAtRisk":202}]},{"term":"Toothache","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":1,"numAffected":1,"numAtRisk":203},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":50},{"groupId":"EG005","numEvents":1,"numAffected":1,"numAtRisk":203},{"groupId":"EG006","numEvents":1,"numAffected":1,"numAtRisk":200},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":202}]},{"term":"Dermatitis contact","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":1,"numAffected":1,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":50},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":0},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":200},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":202}]},{"term":"Pelvic prolapse","organSystem":"Reproductive system and breast disorders","sourceVocabulary":"MedDRA (13.0)","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numEvents":0,"numAffected":0,"numAtRisk":49},{"groupId":"EG001","numEvents":0,"numAffected":0,"numAtRisk":204},{"groupId":"EG002","numEvents":0,"numAffected":0,"numAtRisk":201},{"groupId":"EG003","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG004","numEvents":1,"numAffected":1,"numAtRisk":50},{"groupId":"EG005","numEvents":0,"numAffected":0,"numAtRisk":203},{"groupId":"EG006","numEvents":0,"numAffected":0,"numAtRisk":200},{"groupId":"EG007","numEvents":0,"numAffected":0,"numAtRisk":202}]}]},"moreInfoModule":{"certainAgreement":{"piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true,"otherDetails":"CSL agreements and restrictions on publishing may vary with individual investigators; however, CSL will not prohibit any investigator from publishing. CSL supports the publication of results from all centers of a multi-center trial and generally requires that reports based on single-site data not precede the primary publication of the entire clinical trial."},"pointOfContact":{"title":"Clinical Trials Disclosure Manager","organization":"Seqirus","email":"Seqirus.ClinicalTrials@Seqirus.com"}}},"derivedSection":{"miscInfoModule":{"versionHolder":"2026-11-09"},"conditionBrowseModule":{"meshes":[{"id":"D007251","term":"Influenza, Human"}],"ancestors":[{"id":"D012141","term":"Respiratory Tract Infections"},{"id":"D007239","term":"Infections"},{"id":"D009976","term":"Orthomyxoviridae Infections"},{"id":"D012327","term":"RNA Virus Infections"},{"id":"D014777","term":"Virus Diseases"},{"id":"D012140","term":"Respiratory Tract Diseases"}]}},"hasResults":true}